Denali Therapeutics, Inc. (DNLI)
19.82
-1.02
(-4.89%)
USD |
NASDAQ |
Feb 10, 16:00
19.76
-0.06
(-0.30%)
After-Hours: 20:00
Denali Therapeutics EPS Diluted (Quarterly) : -0.736 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Protalix Biotherapeutics, Inc. | 0.0291 |
| Enovis Corp. | -9.990 |
| Masimo Corp. | -1.859 |
| Twist Bioscience Corp. | -0.4995 |
| Agenus, Inc. | 1.944 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -126.90M |
| Total Expenses (Quarterly) | 126.90M |
| Enterprise Value | 2.291B |
| Earnings Yield | -14.69% |
| Normalized Earnings Yield | -14.69 |